Results 151 to 160 of about 71,064 (224)

Glymphatic Dysfunction, Brain Damage, and Clinical Disability in Spinocerebellar Ataxia Type 3. [PDF]

open access: yesMov Disord
Guo J   +11 more
europepmc   +1 more source

IGFBP1 as a metabolic-neurodegenerative biomarker in spinocerebellar ataxia type 3. [PDF]

open access: yesExp Ther Med
Chiu C   +8 more
europepmc   +1 more source

Content Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar Ataxia. [PDF]

open access: yesCerebellum
Potashman M   +14 more
europepmc   +1 more source

Domain-dependent uncoupling of the co-chaperone and E3 ubiquitin ligase CHIP underlies heterogeneity in spinocerebellar ataxia 48. [PDF]

open access: yesJ Biol Chem
Altinok S   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy